Dysmenorrhoea effects up to 90% of women of reproductive age, with medical management
options including over-the-counter analgesia or hormonal contraception. There has been a …

Objective: This study sought to investigate the perceptions, barriers, and drivers associated
with medicinal cannabis use among Australian women with primary dysmenorrhea. A …

OBJECTIVE: The endocannabinoid system is involved in pain perception and inflammation.
Cannabis contains delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), which are …

Chronic pelvic pain affects women across all demographics. Its management is complex and
requires a multimodal approach. Cannabis has been legal for medical purposes for many …

METHODS: Patients were identified via a medical record query of commonly used CPT
codes for pelvic pain. Patients were contacted via phone then emailed an anonymous online …

Background The use of cannabis for symptoms of endometriosis was investigated utilising
retrospective archival data from Strainprint Technologies Ltd., a Canadian data technology …

Cannabis has an ancient tradition of usage as a medicine in obstetrics and gynecology. This
study presents that history in the literature to the present era, compares it to current …

Menstrual pain also known as dysmenorrhea is one of the most common and underrated
gynecological disorders affecting menstruating women. Although the symptoms and impact …

Hyperemesis gravidarum (HG), a debilitating ailment characterized by severe nausea and
vomiting, malnutrition, and weight loss during pregnancy, occurs to 1–2% of pregnant …

Objective To provide health care providers with the best evidence on cannabis use with
respect to women's health. Areas of focus include general patterns of cannabis use as well …